产品详情
靶点信息
MEK1/2 | ||||
In vitro | DMSO | 105 mg/mL (187.13 mM) | |
Water | Insoluble | ||
Ethanol | 13 mg/mL (23.17 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 17.82 mL | 89.11 mL | 178.22 mL |
0.5 mM | 3.56 mL | 17.82 mL | 35.64 mL |
1 mM | 1.78 mL | 8.91 mL | 17.82 mL |
5 mM | 0.36 mL | 1.78 mL | 3.56 mL |
*The above data is based on the productmolecular weight 561.1 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10704 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 561.1 |
Formula | C16H13BrF3IN2O4 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 391210-00-7 |
Synonyms | PD-318088 |
SMILES | C1=CC(=C(C=C1I)F)NC2=C(C(=C(C=C2C(=O)NOCC(CO)O)Br)F)F |
产品标签
Product Questions
Product Questions
GDC-0973 (Cobimetinib)
GDC-0973 (Cobimetinib,RG7420)是一种有效且高度选择性的MEK1抑制剂,IC50为4.2 nM,对MEK1的选择性选择性是对MEK2的10…
AS703026 (Pimasertib)
AS703026 (Pimasertib)是一种新型的,选择性的,口服可生物利用的MEK1/2抑制剂,可抑制MM细胞的生长和存活以及…
Ulixertinib (BVD-523, VRT752271)
Ulixertinib (BVD-523,VRT752271)是ERK蛋白激酶的吡咯抑制剂。
Cobimetinib (R-enantiomer)
Cobimetinib R-enantiomer是Cobimetinib的R对映异构体,Cobimetinib是一种有力的,高选择性的促分裂原活化蛋白激酶(…
PD184352 (CI-1040)
PD184352 (CI-1040)是一种ATP非竞争性MEK1/2抑制剂,在基于细胞的测定中,IC50为17 nM,对MEK1/2的选择性是对MEK5的1…
Refametinib (RDEA-119, BAY 86-9766)
Refametinib (RDEA-119,BAY 86-9766)是一种口服生物利用型选择性MEK抑制剂,EC50为 2.0-15 nM。具有潜在的抗肿瘤活性…